Abstract
Ocular graft vs. host disease experience from MD Anderson Cancer Center: Newly described clinical spectrum and new approach to the management of stage III and IV ocular GVHD
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have